Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting MDA5-Mediated Interferon Responses in Type 1 Diabetes: Structural Insights, Mechanism, and Potential Therapeutic Approaches.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2026
Same author

A murine model of sepsis induces age- and sex-specific chromatin remodeling in myeloid-derived suppressor cells.

Frontiers in immunology·2026
Same author

Divergent chromatin remodeling trajectories in CD66b <sup>+</sup> MDSCs distinguishes recovery from chronic critical illness after sepsis.

bioRxiv : the preprint server for biology·2026
Same author

Protective <i>IFIH1</i> variant reduces immune-mediated islet stress and dysfunction in a type 1 diabetes genetic background.

bioRxiv : the preprint server for biology·2026
Same author

Prolonged Loss of Oxidative Phosphorylation and Mitochondrial Mass Characterize CD66b<sup>+</sup> Leukocytes from Patients with Sepsis.

bioRxiv : the preprint server for biology·2025
Same author

Single-Islet Proteomics Maps Pseudo-Temporal Islet Immune Responses and Dysfunction in Stage 1 Type 1 Diabetes.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: May 19, 2026

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
12:32

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

Oxidative stress and beta cell dysfunction.

Yaíma L Lightfoot1, Jing Chen, Clayton E Mathews

  • 1Department of Pathology, University of Florida College of Medicine, Gainesville, FL, USA.

Methods in Molecular Biology (Clifton, N.J.)
|August 31, 2012
PubMed
Summary

Type 1 Diabetes (T1D) results from autoimmune destruction of insulin-producing beta cells. Free radicals, including reactive oxygen and nitrogen species, are key players in T1D pathogenesis, causing beta cell dysfunction.

More Related Videos

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals
07:39

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals

Published on: June 25, 2018

A High-content In Vitro Pancreatic Islet &#946;-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

Related Experiment Videos

Last Updated: May 19, 2026

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
12:32

High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds

Published on: January 23, 2018

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals
07:39

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals

Published on: June 25, 2018

A High-content In Vitro Pancreatic Islet &#946;-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

Area of Science:

  • Immunology
  • Endocrinology
  • Cell Biology

Background:

  • Type 1 Diabetes (T1D) is an autoimmune disease causing insulin dependence due to beta cell destruction.
  • Pancreatic insulitis, or islet cell inflammation, precedes beta cell death and T1D onset.
  • Innate immune cells in insulitis lesions release chemokines and cytokines, recruiting adaptive immune cells.

Purpose of the Study:

  • To investigate the role of free radicals in Type 1 Diabetes pathogenesis.
  • To understand how cytokines contribute to beta cell dysfunction in T1D.
  • To explore the link between immune cell activity and oxidative stress in T1D.

Main Methods:

  • Review of existing literature on T1D pathogenesis, insulitis, and immune cell involvement.
  • Analysis of the mechanisms by which cytokines affect beta cell function.
  • Examination of the role of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in beta cell damage.

Main Results:

  • Cytokines increase immune surveillance of beta cells and induce dysfunction.
  • Beta cells generate ROS and RNS, contributing to their own dysfunction.
  • Activated macrophages secrete high levels of ROS and RNS.
  • Beta cells have low intrinsic antioxidant capacities, making them vulnerable.

Conclusions:

  • Free radicals (ROS and RNS) are implicated as critical effectors in Type 1 Diabetes pathogenesis.
  • The interplay between immune cell-derived free radicals and beta cell vulnerability drives T1D progression.
  • Understanding these mechanisms is crucial for developing T1D therapeutic strategies.